Epidermal lipoxygenase products of the hepoxilin pathway selectively activate the nuclear receptor PPARalpha.
Arachidonic acid can be transformed into a specific epoxyalcohol product via the sequential action of two epidermal lipoxygenases, 12R-LOX and eLOX3. Functional impairment of either lipoxygenase gene (ALOX12B or ALOXE3) results in ichthyosis, suggesting a role for the common epoxyalcohol product or its metabolites in the differentiation of normal human skin. Here we tested the ability of products derived from the epidermal LOX pathway to activate the peroxisome proliferator-activated receptors PPARalpha, gamma, and delta, which have been implicated in epidermal differentiation. Using a dual luciferase reporter assay in PC3 cells, the 12R-LOX/eLOX3-derived epoxyalcohol, 8R-hydroxy-11R,12R-epoxyeicosa-5Z,9E,14Z-trienoic acid, activated PPARalpha with similar in potency to the known natural ligand, 8S-hydroxyeicosatetraenoic acid (8S-HETE) (both at 10 microM concentration). In contrast, the PPARgamma and PPARdelta receptor isoforms were not activated by the epoxyalcohol. Activation of PPARalpha was also observed using the trihydroxy hydrolysis products (trioxilins) of the unstable epoxyalcohol. Of the four trioxilins isolated and characterized, the highest activation was observed with the isomer that is also formed by enzymatic hydrolysis of the epoxyalcohol. Formation of a ligand for the nuclear receptor PPARalpha may be one possibility by which 12R-LOX and eLOX3 contribute to epidermal differentiation.
Yu
Zheyong
Z
Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University School of Medicine, 23rd Ave. at Pierce, Nashville, TN 37232-6602, USA.
Schneider
Claus
C
Boeglin
William E
WE
Brash
Alan R
AR
D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid / Q000378:metabolism; D015126:8,11,14-Eicosatrienoic Acid / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D001091:Arachidonate Lipoxygenases / Q000378:metabolism*; D002454:Cell Differentiation; D002460:Cell Line; D000078404:Epidermal Cells; D004817:Epidermis / Q000201:enzymology*; D017930:Genes, Reporter; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000378:metabolism; D008084:Lipoxygenase / Q000378:metabolism; D008156:Luciferases / Q000235:genetics / Q000378:metabolism; D047493:PPAR alpha / Q000378:metabolism*; D047494:PPAR delta / Q000378:metabolism; D047495:PPAR gamma / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D015398:Signal Transduction
C515338:11,12-epoxyeicosatrienoic acid methyl ester; D006893:Hydroxyeicosatetraenoic Acids; D047493:PPAR alpha; D047494:PPAR delta; D047495:PPAR gamma; D018160:Receptors, Cytoplasmic and Nuclear; D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; C038243:8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid; D001091:Arachidonate Lipoxygenases; C511051:ALOXE3 protein, human; D008084:Lipoxygenase; D008156:Luciferases; D015126:8,11,14-Eicosatrienoic Acid